Synergistic antitumor activity of cyclophosphamide and ABPP in the treatment of established and advanced tumors in murine tumor models

Keyphrases

• Tumor 100%
• Cyclophosphamide 100%
• Advanced Tumor 100%
• Murine Tumor Model 100%
• Synergistic Antitumor Activity 100%
• Treatment Cycle 40%
• In Vivo Applications 20%
• Tumor Cells 20%
• Interferon-α (IFN-α) 20%
• Natural Killer Cells 20%
• Pulmonary Metastasis 20%
• Lysis 20%
• Multiple Treatments 20%
• Pyrimidinone 20%
• Metastasis Model 20%
• Moderate Dose 20%
• Immunogenic Tumor 20%
• Non-immunogenic 20%
• Release Assay 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Cyclophosphamide 100%
• Antitumor Activity 100%
• Tumor Model 100%
• Interferon 12%
• Lung Metastasis 12%
• Pyrimidinone Derivative 12%
• Multiple Cycle Treatment 12%

Immunology and Microbiology

• Cyclophosphamide 100%
• Antineoplastic Activity 100%
• Tumor Cell 50%
• interferon 50%
• Killer Cell 50%
• Multiple Cycle Treatment 50%